These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23894335)

  • 1. Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort study.
    Jamilloux Y; Liozon E; Pugnet G; Nadalon S; Heang Ly K; Dumonteil S; Gondran G; Fauchais AL; Vidal E
    PLoS One; 2013; 8(7):e68713. PubMed ID: 23894335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
    Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
    Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009).
    Chandran A; Udayakumar PD; Kermani TA; Warrington KJ; Crowson CS; Matteson EL
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-98-102. PubMed ID: 26016757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.
    de Boysson H; Boutemy J; Creveuil C; Ollivier Y; Letellier P; Pagnoux C; Bienvenu B
    Semin Arthritis Rheum; 2013 Aug; 43(1):105-12. PubMed ID: 23453684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
    J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis.
    Dumont A; Parienti JJ; Delmas C; Boutemy J; Maigné G; Martin Silva N; Sultan A; Planchard G; Aouba A; de Boysson H
    J Rheumatol; 2020 Jan; 47(1):108-116. PubMed ID: 30877210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerance of methotrexate in a real-life monocentric cohort of patients with giant cell arteritis.
    Lavergne A; Dumont A; Deshayes S; Boutemy J; Maigné G; Silva NM; Nguyen A; Gallou S; Philip R; Aouba A; de Boysson H
    Semin Arthritis Rheum; 2023 Jun; 60():152192. PubMed ID: 36963127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
    Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A French cohort of patients with giant cell arteritis: glucocorticoid treatment and its associated side effects.
    Perrineau S; Ghesquière T; Charles P; Paule R; Samson M; Gayraud M; Chauvin A; Terrier B; Guillevin L; Bonnotte B; Mouthon L; Régent A;
    Clin Exp Rheumatol; 2021; 39 Suppl 129(2):155-160. PubMed ID: 33938796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of Graves' orbitopathy treatment with intravenous glucocorticoids on adrenal function.
    Ambroziak U; Bluszcz G; Bednarczuk T; Miśkiewicz P
    Endokrynol Pol; 2017; 68(4):430-433. PubMed ID: 28604944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oral cyclophosphamide in the treatment of giant cell arteritis.
    Quartuccio L; Maset M; De Maglio G; Pontarini E; Fabris M; Mansutti E; Mariuzzi L; Pizzolitto S; Beltrami CA; De Vita S
    Rheumatology (Oxford); 2012 Sep; 51(9):1677-86. PubMed ID: 22627726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?
    de Boysson H; Liozon E; Lambert M; Dumont A; Boutemy J; Maigné G; Martin Silva N; Ly KH; Manrique A; Bienvenu B; Aouba A
    Am J Med; 2017 Aug; 130(8):992-995. PubMed ID: 28460851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of Adrenal Function in Patients with Glucocorticoids Induced Secondary Adrenal Insufficiency.
    Baek JH; Kim SK; Jung JH; Hahm JR; Jung J
    Endocrinol Metab (Seoul); 2016 Mar; 31(1):153-60. PubMed ID: 26676337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency.
    Suliman AM; Smith TP; Labib M; Fiad TM; McKenna TJ
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):533-9. PubMed ID: 11966747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
    J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.